These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9037454)

  • 21. Coming back to life Montreal.
    Hoag H
    Nature; 2004 Jul; 430(6996):274-5. PubMed ID: 15241427
    [No Abstract]   [Full Text] [Related]  

  • 22. Prescription for an ailing pharmaceutical industry.
    Demain AL
    Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
    [No Abstract]   [Full Text] [Related]  

  • 23. Stepping up to the plate.
    Nat Immunol; 2008 Jan; 9(1):1. PubMed ID: 18087245
    [No Abstract]   [Full Text] [Related]  

  • 24. Toronto rising.
    Kleiner K
    Nature; 2008 May; 453(7192):252-3. PubMed ID: 18561361
    [No Abstract]   [Full Text] [Related]  

  • 25. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growing pains for biopharmaceuticals.
    Ashton G
    Nat Biotechnol; 2001 Apr; 19(4):307-11. PubMed ID: 11283578
    [No Abstract]   [Full Text] [Related]  

  • 27. Merck moves into biotech.
    Kling J
    Nat Biotechnol; 2006 Jul; 24(7):730. PubMed ID: 16841041
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug development in oncology. Its status and outlook with special consideration of the position of Germany].
    Strohmeyer T; Weissbach L
    Dtsch Med Wochenschr; 1999 Feb; 124(8):231-5. PubMed ID: 10093574
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacology and pharmacotherapy in Japan].
    Van Zwieten PA
    Ned Tijdschr Geneeskd; 1990 Mar; 134(11):549-50. PubMed ID: 2320149
    [No Abstract]   [Full Text] [Related]  

  • 30. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concerns raised over declining antiinfectives R&D.
    Fox JL
    Nat Biotechnol; 2003 Nov; 21(11):1255-6. PubMed ID: 14595340
    [No Abstract]   [Full Text] [Related]  

  • 32. A status report on neuroscience research, without grade inflation.
    Johnston SC; Hauser SL
    Ann Neurol; 2006 Dec; 60(6):A9-11. PubMed ID: 17192939
    [No Abstract]   [Full Text] [Related]  

  • 33. Diabetes research investment in the European Union.
    Halban PA; Ferrannini E; Nerup J
    Nat Med; 2006 Jan; 12(1):70-2. PubMed ID: 16397573
    [No Abstract]   [Full Text] [Related]  

  • 34. Science, medicine and... the markets.
    Pawlotsky JM
    J Hepatol; 2006 Sep; 45(3):341-2. PubMed ID: 16854496
    [No Abstract]   [Full Text] [Related]  

  • 35. What drives operational performance in clinical R&D?
    Ringel M; Martin L; Hawkins C; Panier V; Denslow M; Buck L; Schulze U
    Nat Rev Drug Discov; 2016 Mar; 15(3):155-6. PubMed ID: 26846158
    [No Abstract]   [Full Text] [Related]  

  • 36. Property rights go East.
    Nature; 2005 Nov; 438(7067):420-1. PubMed ID: 16306959
    [No Abstract]   [Full Text] [Related]  

  • 37. US drug industry hurt by rising research costs and slumping prices, report says.
    Rafuse J
    CMAJ; 1994 Apr; 150(8):1306. PubMed ID: 8162554
    [No Abstract]   [Full Text] [Related]  

  • 38. Back to the future.
    Offit P
    Expert Rev Vaccines; 2004 Apr; 3(2):107-8. PubMed ID: 15056035
    [No Abstract]   [Full Text] [Related]  

  • 39. Rediscovering plant-based drugs.
    Littleton J; Falcone D; Davies HM
    Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
    [No Abstract]   [Full Text] [Related]  

  • 40. An audience with...Marc Cluzel.
    Cluzel M
    Nat Rev Drug Discov; 2010 Jan; 9(1):14. PubMed ID: 20043024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.